Real-world evidence of Besponsa in Belgium in acute lymphoblastic leukemia patients according to the prevailing reimbursement criteria Last updated: 2023-05-25 18:01
Efficient access to patients with renal impairment for drug safety study Last updated: 2023-02-03 03:36